Financials
- Market Capitalization 8.04 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-9.02
売上高対価格比率
51.72
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1023 | TGTX TG Therapeutics, Inc. - Common Stock | 55.85 USD | +1.75% | -1.33% | +11.39% | +45.86% | 8.55 B USD | ||
| 1033 | PCVX Vaxcyte, Inc. - Common Stock | 56.38 USD | +0.30% | -2.66% | +13.74% | +33.29% | 8.14 B USD | ||
| 1042 | IMVT Immunovant, Inc. - Common Stock | 39.44 USD | +1.73% | -1.42% | +18.76% | +105.31% | 8.10 B USD | ||
| 1061 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.94 USD | -0.06% | -3.92% | +18.66% | +56.24% | 7.74 B USD |